Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kerins Patrick J
Relationship:   10% Owner
City:   Baltimore
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   2,400,049    

Indirect Shares

   216,112,072      
Direct Value   $2,666,741    

Indirect Value

   $660,561,111      
Total Shares   218,512,121      
Total Value   $663,227,853      


Hemosense Inc $0 Echo Global Logistics Inc $4,679 Groupon, Inc. $11,042 Clovis Oncology, Inc. $9 Millennial Media Inc $0 Workday, Inc. $426,168 Channeladvisor Corp $827,846 Epizyme, Inc. $957 Care.com Inc $7,555 Ardelyx Inc $87,987 Mersana Therapeutics, Inc. $9,740 Appian Corp $49,102 Cloudflare, Inc. $0 Sprout Social, Inc. $1,090,147 Coursera, Inc. $0 BuzzFeed, Inc $93,172 Sagimet Biosciences Inc. $58,337 Hemosense Inc $0 Echo Global Logistics Inc $4,679 Groupon, Inc. $11,042 Clovis Oncology, Inc. $9 Millennial Media Inc $0 Workday, Inc. $426,168 Channeladvisor Corp $827,846 Epizyme, Inc. $957 Care.com Inc $7,555 Ardelyx Inc $87,987 Mersana Therapeutics, Inc. $9,740 Appian Corp $49,102 Cloudflare, Inc. $0 Sprout Social, Inc. $1,090,147 Coursera, Inc. $0 BuzzFeed, Inc $93,172 Sagimet Biosciences Inc. $58,337
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -59.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Hemosense Inc HEM 10% Owner 2006-12-12 1,772,151 0    Premium*  
            Aryx Therapeutics Inc ARYX 10% Owner 0 2011-03-10 0    Premium*  
            Echo Global Logistics Inc ECHO 10% Owner 2012-02-28 97 2012-02-28 0    Premium*  
            Viracta Therapeutics Ord Shs VIRX 10% Owner 2010-06-30 0 2014-08-29 4,659,333    Premium*  
            Groupon, Inc. GRPN 10% Owner 2013-09-13 7,944 2013-09-13 0    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-03 575 2013-06-03 0    Premium*  
            Millennial Media Inc MM Director 2015-10-22 15,625 2015-10-22 0    Premium*  
            Tesaro, Inc. TSRO 10% Owner 2019-01-22 0 2019-01-22 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2015-05-07 0 2015-05-07 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-10 1,730 2013-04-10 0    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Channeladvisor Corp ECOM Director 2016-03-01 35,853 2015-12-14 0    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2016-01-12 651 2016-01-12 6,260,851    Premium*  
            Care.com Inc CRCM 10% Owner 2017-11-06 504 2017-11-06 0    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Ardelyx Inc ARDX 10% Owner 2020-06-10 11,324 2020-06-10 0    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2018-09-07 82,978,668    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2020-09-14 3,594 2020-09-14 0    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 1,523 2018-02-13 0    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2018-07-30 0 2018-07-30 2,484,870    Premium*  
            Oyster Point Pharma, Inc. OYST 10% Owner 0 2019-10-30 5,925,287    Premium*  
            Cloudflare, Inc. NET 10% Owner 2020-11-11 203,454 2020-11-11 0    Premium*  
            Sprout Social, Inc. SPT 10% Owner 2020-11-13 38,644 2020-11-13 0    Premium*  
            Coursera, Inc. COUR 10% Owner 2021-05-19 70,394 2021-05-19 0    Premium*  
            BuzzFeed, Inc BZFD Director, 10% Owner 2023-12-03 222,847 2023-12-03 15,333,892    Premium*  
            Sagimet Biosciences Inc. SGMT 10% Owner 2024-01-29 13,139 2024-01-29 0    Premium*  
* Premium Members only  

Records found :    217         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2016-01-01 3 IO $0.00 $0 I/I 0 59,269,000 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2017-03-27 4 B $0.70 $9,009,000 I/I 12,870,000 72,139,000 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-21 4 B $1.81 $189,820 I/I 104,844 72,243,844 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-22 4 B $1.90 $1,655,669 I/I 869,574 73,113,418 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-23 4 B $1.95 $572,358 I/I 294,090 73,407,508 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-26 4 B $1.90 $1,087,553 I/I 571,164 73,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-03-27 4 B $1.92 $11,500,200 I/I 6,000,000 79,978,672 1.5 -
ADAP Adaptimmune Therapeutics ... 10% Owner   –       –       •   2018-09-07 4 B $1.67 $5,000,100 I/I 3,000,000 82,978,668 1.5 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-20 4 S $19.49 $54,971,857 I/I (2,820,516) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-20 4 A $0.00 $0 I/I 2,820,516 2,820,516 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-27 4 S $19.49 $11,101,894 I/I (569,620) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2017-11-27 4 A $0.00 $0 I/I 569,620 569,620 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 I/I 2,724,202 2,724,202 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 D/D 1,523 1,523 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 D $0.00 $0 I/I (2,765,065) 0 0 -
APPN Appian Corp 10% Owner   –       –       •   2018-02-13 4 A $0.00 $0 I/I 40,863 13,621 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2014-12-23 4 A $0.00 $0 D/D 241 241 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2014-12-23 4 D $0.00 $0 I/I (10,000) 0 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2015-06-05 4 B $10.70 $20,000,001 I/I 1,869,159 7,488,893 1.5 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2016-01-13 4 B $10.00 $5,000,000 I/I 500,000 7,988,893 1.5 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2018-05-25 4 A $4.00 $1,666,668 I/I 416,667 9,169,210 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2019-12-09 4 A $6.25 $2,500,000 I/I 400,000 9,569,210 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2020-06-10 4 A $0.00 $0 I/I 455,222 455,222 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2020-06-10 4 A $0.00 $0 D/D 11,083 11,324 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2020-06-10 4 D $0.00 $0 I/I (1,938,031) 0 0 -
  217  Records found
  1  2   3   4   5   6   7   8   9      
  Page 1 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us